375
Views
3
CrossRef citations to date
0
Altmetric
Review

Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases

, , , , , , , , , , & ORCID Icon show all
Pages 949-967 | Received 27 Apr 2021, Accepted 05 Aug 2021, Published online: 30 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria Francesca Beatino, Ciro De Luca, Nicole Campese, Elisabetta Belli, Rebecca Piccarducci, Linda Giampietri, Claudia Martini, Giulio Perugi, Gabriele Siciliano, Roberto Ceravolo, Andrea Vergallo, Harald Hampel & Filippo Baldacci. (2022) α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease. Expert Review of Molecular Diagnostics 22:4, pages 411-425.
Read now

Articles from other publishers (2)

Amanda Li, Cyrus Rastegar & Xiaobo Mao. (2022) α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications. Biomolecules 12:7, pages 994.
Crossref
Linda Giampietri, Elisabetta Belli, Maria Francesca Beatino, Sara Giannoni, Giovanni Palermo, Nicole Campese, Gloria Tognoni, Gabriele Siciliano, Roberto Ceravolo, Ciro De Luca & Filippo Baldacci. (2022) Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments. Diagnostics 12:4, pages 796.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.